by GAtherton | Jan 5, 2022 | General interest, Information and Learning
Allergic broncho pulmonary aspergillosis (ABPA) and chronic pulmonary aspergillosis (CPA) are two different types of aspergillosis. They are both chronic diseases but they differ in mechanisms and often presentation. Do you know the differences between the two? This...
by GAtherton | Dec 10, 2021 | General interest, Information and Learning, Latest research news
This article was published by the Cystic Fibrosis Foundation and is a personal account of a young woman with CF and trying to come to terms with the limitations that loss of lung function has placed on her young life. There is a grief for her lost life, the one where...
by Lauren Amphlett | Nov 22, 2021 | COVID-19, General interest, Information and Learning
Vaccines. Something most, if not all of us, are familiar with. MMR (Measles, Mumps & Rubella), TB (Tuberculosis), Smallpox, Chicken Pox, and the more recent HPV (Human Papillomavirus) and Covid-19 vaccines are just a few of the many available to protect us from...
by Lauren Amphlett | Nov 15, 2021 | General interest, Information and Learning, Lifestyle and Coping Skills, Living with Aspergillosis, Patient and Carer Blog
Cecilia Williams suffers from aspergillosis in the form of an aspergilloma and Chronic Pulmonary Aspergillosis (CPA). In this post, Cecilia talks about how a light but regular exercise regime has helped improve her health and wellbeing. I downloaded the...
by GAtherton | Oct 14, 2021 | General interest, Information and Learning, Lifestyle and Coping Skills, Living with Aspergillosis
One of the subjects discussed at our online weekly patient & carer support meeting for the National Aspergillosis Centre in Manchester, UK this week was the importance of maintaining our health & wellness so that we may maintain our best possible quality of...
by Lauren Amphlett | Oct 8, 2021 | Antifungals in development, General interest, Information and Learning, Latest research news
Many of our patients already know of the increasing need for new antifungal drugs; treatments for fungal diseases like aspergillosis have significant limitations. Toxicities, drug-drug interactions, resistance, and dosing are all issues that can complicate therapy;...